| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 117.46B | 112.98B | 109.95B | 110.92B | 105.39B |
| Gross Profit | 60.08B | 54.98B | 51.62B | 54.05B | 55.47B |
| EBITDA | 20.25B | 18.59B | 16.13B | 18.61B | 22.60B |
| Net Income | 11.68B | 9.26B | 7.67B | 9.27B | 12.80B |
Balance Sheet | |||||
| Total Assets | 173.26B | 159.83B | 161.09B | 152.24B | 153.26B |
| Cash, Cash Equivalents and Short-Term Investments | 49.31B | 50.09B | 45.66B | 36.83B | 45.71B |
| Total Debt | 3.56B | 6.07B | 7.19B | 4.14B | 4.12B |
| Total Liabilities | 40.54B | 35.06B | 35.04B | 34.72B | 38.82B |
| Stockholders Equity | 132.72B | 124.27B | 125.52B | 117.29B | 114.20B |
Cash Flow | |||||
| Free Cash Flow | 13.77B | 18.63B | 13.94B | 1.97B | 13.09B |
| Operating Cash Flow | 17.88B | 21.07B | 16.57B | 6.11B | 16.03B |
| Investing Cash Flow | -14.68B | -3.92B | -3.64B | -5.22B | -8.71B |
| Financing Cash Flow | -6.41B | -12.26B | -6.58B | -11.41B | -13.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥18.54T | 24.82 | 12.80% | 0.78% | 10.40% | 11.67% | |
83 Outperform | ¥327.30B | 13.13 | 25.32% | 2.30% | 15.50% | 12.62% | |
81 Outperform | ¥153.25B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
78 Outperform | ¥906.25B | 12.89 | 11.99% | 0.65% | 4.95% | 10.47% | |
70 Outperform | ¥513.46B | 16.37 | 7.44% | 1.76% | 3.97% | 29.53% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |